江苏联环药业股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ?每股分配比例 A 股每股现金红利0.089元 证券代码：600513 证券简称：联环药业 公告编号：2025-037 ?相关日期 股份类别 股权登记日 最后交易日 除权（息）日 现金红利发放日 Ａ股 2025/6/20 － 2025/6/23 2025/6/23 ?差异化分红送转：否 一、通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 5 月 9 日的2024年年度股东会审议通过。 二、分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 三、相关日期 股份类别 股权登记日 最后交易日 除权（息）日 现金红利发放日 Ａ股 2025/6/20 － 2025/6/23 2025/6/23 四、分配实施办法 （1）无限售条件流通股的红利委托中国结算上海分公司通过其资金清算系统 向股权登记日上海证券交易所收市后登记在册并在上海 ...

常山药业：艾本那肽注射液用于减重适应症的临床试验申请获得批准 智通财经6月20日电，常山药业(300255.SZ)公告称，常山药业及控股子公司常山凯捷健近日收到国家药 品监督管理局核准签发的《药物临床试验批准通知书》，艾本那肽注射液用于减重适应症的临床试验申 请获得批准。艾本那肽是一种长效胰高血糖素样肽-1受体激动剂，通过激活GLP-1受体以葡萄糖浓度依 赖的方式刺激胰岛素分泌和抑制胰高糖素分泌，同时增加肌肉和脂肪组织葡萄糖摄取，抑制肝脏葡萄糖 的生成而发挥降糖作用。根据药品注册相关的法律法规要求，药物在获得临床试验批准通知书后，尚需 完成后续临床试验并经国家药品监督管理局审评、审批通过后方可上市。本次获取临床试验批准通知书 不会对公司近期业绩产生重大影响。药品在取得临床试验许可后，尚需开展临床试验，临床研究受到多 种不确定因素影响，存在结果不及预期甚至临床研究失败的风险。药品研发存在投入大、周期长、风险 高等特点，药物从临床试验到投产上市会受到技术、审批、政策等多方面因素的影响，临床试验进度及 结果、未来产品市场竞争形势均存在诸多不确定性。 ...

Market Overview - The FTSE China A50 Index components showed a mixed performance with the banking and insurance sectors continuing to rise in the afternoon, while the consumer electronics sector experienced divergent trends [1][7]. Banking and Insurance Sector - Major banks and insurance companies such as China Pacific Insurance, Ping An Insurance, and China Life Insurance reported market capitalizations of 376.78 billion, 340.36 billion, and 996.83 billion respectively, with trading volumes of 7.95 million, 46.06 million, and 6.95 million [3]. - The insurance sector saw positive changes with Ping An Insurance increasing by 1.54 (+2.89%) and China Life Insurance by 0.14 (+1.67%) [3]. Consumer Electronics Sector - The consumer electronics sector displayed mixed results, with companies like Industrial Fulian and Luxshare Precision reporting market capitalizations of 408.89 billion and 240.74 billion respectively, and trading volumes of 39.50 million and 10.37 million [4]. - Industrial Fulian's stock decreased by 0.22 (-1.06%), while Luxshare Precision increased by 0.18 (+0.35%) [4]. Alcohol Industry - The alcohol sector, represented by Kweichow Moutai and Wuliangye, showed strong market capitalizations of 1,794.68 billion and 223.79 billion respectively, with trading volumes of 49.91 million and 21.95 million [3]. - Kweichow Moutai's stock increased by 2.66 (+0.19%), while Wuliangye rose by 6.84 (+3.87%) [3]. Semiconductor Sector - The semiconductor industry, including companies like North Huachuang and Cambrian, reported market capitalizations of 227.97 billion and 310.30 billion respectively, with trading volumes of 14.35 million and 21.38 million [3]. - North Huachuang's stock increased by 3.21 (+0.76%), while Cambrian's stock decreased by 8.11 (-1.39%) [3]. Automotive Sector - The automotive sector, featuring Great Wall Motors and BYD, had market capitalizations of 179.31 billion and 1,869.56 billion respectively, with trading volumes of 25.08 million and 3.83 million [3]. - Great Wall Motors' stock decreased by 0.25 (-0.07%), while BYD's stock decreased by 0.16 (-0.76%) [3]. Energy Sector - The energy sector, including China Petroleum and China Shenhua, reported market capitalizations of 1,676.47 billion and 1,095.42 billion respectively, with trading volumes of 12.62 million and 8.75 million [3]. - China Petroleum's stock increased by 0.21 (+1.30%), while China Shenhua's stock decreased by 1.84 (-0.76%) [3].

Group 1: Market Overview - The FTSE China A50 Index components showed a rebound in banking, insurance, and liquor sectors, while the power sector continued to adjust [1][4][5] - Major insurance companies like China Pacific Insurance, China Life Insurance, and Ping An Insurance reported market capitalizations of 378.55 billion, 342.10 billion, and 994.83 billion respectively, with trading volumes of 4.88 million, 24.23 million, and 3.99 million [4] - The liquor industry, led by Kweichow Moutai, Wuliangye, and Shanxi Fenjiu, had market capitalizations of 1807.87 billion, 225.39 billion, and 463.74 billion respectively, with trading volumes of 27.96 million, 15.85 million, and 20.97 million [4] Group 2: Sector Performance - The semiconductor sector, including companies like Northern Huachuang and Cambrian, had market capitalizations of 226.75 billion and 240.86 billion respectively, with trading volumes of 7.87 million and 14.31 million [4] - In the automotive sector, Great Wall Motors and BYD reported market capitalizations of 281.32 billion and 1874.12 billion respectively, with trading volumes of 13.90 million and 1.60 million [4] - The power sector, represented by companies like Yangtze Power and China Nuclear Power, had market capitalizations of 746.53 billion and 329.67 billion respectively, with trading volumes of 9.73 million and 16.36 million [5] Group 3: Notable Companies - China Shenhua Energy and Shaanxi Coal and Chemical Industry had market capitalizations of 193.12 billion and 1095.10 billion respectively, with trading volumes of 4.57 million and 18.81 million [4] - In the food and beverage sector, companies like Citic Securities and Haitai Flavor reported market capitalizations of 385.04 billion and 325.62 billion respectively, with trading volumes of 5.48 million and 3.31 million [5] - The electronics sector, including companies like Industrial Fulian and Luxshare Precision, had market capitalizations of 342.13 billion and 409.89 billion respectively, with trading volumes of 5.39 million and 23.98 million [5]

Core Viewpoint - Multiple companies have announced significant developments, including investments, clarifications on business operations, and changes in control, which may present various investment opportunities and risks for stakeholders [2]. Company Announcements - **Hai Zheng Pharmaceutical** plans to establish a joint venture in synthetic biology with a registered capital of 350 million yuan, where Hai Zheng will contribute 260 million yuan, holding a 74.29% stake [3]. - **Jin Zhong Zi Jiu** clarified that its business scope remains unchanged despite media reports suggesting a shift away from liquor production, confirming that it will continue to focus on its core liquor business [4]. - **ST Gong Zhi** announced that its stock will resume trading on June 20, 2025, and enter a delisting period, with the last trading date expected to be July 10, 2025 [5]. - **Zhong Jing Electronics** confirmed that its production and operational conditions are normal, with no undisclosed significant matters [6]. - **Shan Jin International** is preparing for an overseas H-share issuance and listing on the Hong Kong Stock Exchange to enhance its global strategy [7]. - **Kang Da New Materials** intends to acquire at least 51% of Chengdu Zhongke Huamei Electronics to expand into the semiconductor integrated circuit sector [8]. - **Zhong Yan Chemical** agreed to a capital reduction for its subsidiary, which will result in it holding 100% of the subsidiary's equity, constituting a significant asset restructuring [9]. - **Tai Ji Co., Ltd.** announced a change in its actual controller to the Hubei Provincial State-owned Assets Supervision and Administration Commission, with stock resuming trading [10]. - **ST Yi Guo** plans to sell four Carrefour subsidiaries for 1 yuan, expecting to increase its net profit by approximately 572 million yuan, while focusing on its core home appliance business [11][12]. Performance Expectations - **Sheng Nuo Bio** anticipates a substantial increase in net profit for the first half of 2025, projecting a year-on-year growth of 253.54% to 332.10%, driven by strong performance in its peptide raw material business [13]. Share Buyback - **Nuo Wei Zan** intends to repurchase shares worth between 5 million and 10 million yuan to implement employee stock ownership plans, with a maximum repurchase price of 30 yuan per share [14]. Major Contracts - **Sai Sheng Pharmaceutical** signed a technology transfer contract for a new drug project with a total transaction amount of 20 million yuan, which will enhance its capabilities in the protein/antibody drug platform [15].

Group 1 - The Ministry of Commerce of China will accelerate the review of export license applications related to rare earths, emphasizing compliance and communication with relevant countries to facilitate trade [2] - The Chinese government is committed to maintaining the stability and security of global supply chains while approving a certain number of compliant applications [2] Group 2 - A video conference was held by three departments to strengthen safety management in the new energy vehicle sector, emphasizing the responsibility of vehicle and battery manufacturers for product quality and safety [5] - The meeting highlighted the importance of avoiding exaggerated claims and ensuring long-term quality over short-term cost-cutting measures [5] Group 3 - The Shanghai Stock Exchange has developed an action plan to enhance ESG ratings for listed companies, aiming to improve the quality of ESG information disclosure and attract long-term capital [4] - The action plan includes six key initiatives such as providing rating guidance, improving communication, and enhancing management performance [4] Group 4 - Beijing's municipal government has issued interim support measures to promote the high-quality development of the gaming and esports industry, including financial rewards for successful game projects [6] - The measures aim to foster collaboration between game companies and cultural heritage sites, supporting the development of culturally significant games [6] Group 5 - Several companies have made significant announcements, including: - Zhongsheng Pharmaceutical completed the first participant enrollment in a Phase III clinical trial for RAY1225 injection for obesity [8] - Hunan Haili received support for stock repurchase loans not exceeding 200 million yuan [8] - SF Holding reported a 13.36% year-on-year increase in logistics revenue for May 2025 [8] - Ningde Times plans to use up to 4.5 billion yuan of idle fundraising for cash management [8] - Xiamen Tungsten's high-performance neodymium-iron-boron magnetic material project has commenced production [8]

Group 1 - The core viewpoint of the announcement is the approval of the 2024 profit distribution plan by the shareholders' meeting, which includes a cash dividend of 0.4 yuan per 10 shares [1][2] - The profit distribution plan will be implemented within two months after the shareholders' meeting, with the record date set for June 26, 2025 [2][3] - The cash dividends will be directly credited to shareholders' accounts through their securities companies on June 27, 2025 [3][4] Group 2 - The distribution plan specifies that the total share capital will be adjusted if there are changes due to stock buybacks or other factors, maintaining the dividend distribution ratio [1][2] - Different tax rates will apply to individual and institutional investors based on their holding periods, with specific tax obligations outlined for different categories of shares [2] - The announcement includes contact information for inquiries, indicating the company's commitment to transparency and shareholder communication [3][4]

Market Performance - A-shares experienced significant declines, with the Shanghai Composite Index falling by 0.79% to 3362.11 points, the Shenzhen Composite Index down by 1.50%, and the ChiNext Index decreasing by 1.70% [1] - The total trading volume across A-shares was 12,809 billion, slightly up from 12,218 billion the previous day [1] - In terms of sector performance, oil and gas sectors showed strength, while hotel and restaurant, and banking sectors performed relatively better [1] Geopolitical Impact - Ongoing military conflict between Israel and Iran has escalated, lasting for 7 days, contributing to market volatility and increased risk aversion [1] - A-shares are affected by geopolitical tensions, though to a lesser extent compared to Hong Kong stocks, which saw a notable decline [1] Federal Reserve Update - The Federal Reserve maintained the benchmark interest rate at 4.25%-4.50%, marking the fourth consecutive meeting without a rate change [2] - The "dot plot" indicates that most Fed members expect a 50 basis point rate cut by the end of the year, likely in two 25 basis point increments [2] - Market expectations suggest that the Fed will not cut rates in July, with potential cuts anticipated in September [2]

Group 1 - Chengjian Development received a dividend of 7.1282 million yuan from Beijing Jingcheng Jiaye Property Co., Ltd., in which it holds a 33.47% stake [1] - Shengnuo Bio expects a net profit attributable to shareholders of 77.0275 million to 94.1448 million yuan for the first half of 2025, representing a year-on-year increase of 253.54% to 332.10% [1] - JKN2301 dry mixed suspension has been approved for clinical trials, targeting children with influenza [5][6] Group 2 - Jindawei obtained a patent for a method of purifying natto kinase, with a validity of twenty years [2] - CITIC Guoan plans to increase its stake in China Broadcasting Hunan Company to approximately 5.29% through a capital increase of 278 million yuan [2] - Ji Electric announced the resignation of its general manager, Niu Guojun, due to work changes [3] Group 3 - Xintian Green Energy successfully issued 1.5 billion yuan in green medium-term notes with a term of 3+N years and an interest rate of 2.05% [7] - Hengrun Co. plans to invest 1.2 billion yuan in a project to produce 2,000 sets of wind turbine gearbox components [9] - Pulaide received a government subsidy of 10 million yuan, accounting for 15.87% of its audited net profit for the last fiscal year [10] Group 4 - Boteng Co. passed the EU QP audit, receiving a compliance statement for its CDMO services [12] - Zhou Dasheng added 7 self-operated stores in May, with total investments ranging from 900,000 to 6.5 million yuan [13] - Wantai Bio initiated a Phase III clinical trial for its live attenuated varicella vaccine [15] Group 5 - Shanghai Pharmaceuticals received a drug registration certificate for Pregabalin capsules in Thailand [19] - Sanxing Medical's subsidiary is expected to win contracts worth approximately 143 million yuan from State Grid projects [21] - Jiangsu Huachen plans to issue 460 million yuan in convertible bonds [24] Group 6 - Jian Gong Repair won a soil pollution remediation project worth 32.76 million yuan [25] - Dize Pharmaceutical completed patient enrollment for a global Phase III clinical trial of its drug [26] - Del Co. received acceptance for its application to issue shares for asset acquisition and raise matching funds [27] Group 7 - Beijing Kerui won multiple power grid projects with a total value of approximately 154 million yuan [27] - Xie Chuang Data signed financing lease contracts totaling 498 million yuan with Su Yin Financial Leasing [28] - Meige Intelligent submitted an application for H-share listing on the Hong Kong Stock Exchange [29][31] Group 8 - Aikodi plans to repurchase shares worth 100 million to 200 million yuan for employee stock ownership plans [54] - Kong Kong Industrial intends to sell 80% of Tianyuan Construction to its controlling shareholder [55] - Youyou Green Energy proposed a cash dividend of 12 yuan per 10 shares, totaling 50.4 million yuan [55]

【品大事】 海正药业：拟投资成立合成生物学合资公司 海正药业公告，公司拟与全资子公司瀚晖制药之香港全资子公司辉正国际合资设立合成生物学独立子公 司，注册资本3.5亿元。海正药业拟认缴出资2.6亿元，占74.29%，辉正国际拟认缴出资0.9亿元。合资公 司将整合资源，提升决策效率，为公司合成生物学业务发展提供支撑。 金种子酒：公司经营范围不存在变更主业情况 金种子酒发布澄清公告称，公司近日关注到有关媒体发布题为《经营范围删除"白酒"，金种子酒要转 型？》，《金种子酒不做白酒了？》等相关报道，公司现就相关情况予以澄清说明。公司原经营范 围"白酒和其他酒生产"系公司1998年上市以来在工商登记系统填报信息，没有发生过变更。为使用市场 监管总局统一的《经营范围规范表述目录（试行）》开展经营范围登记规范化工作，根据市场监督管理 局要求，公司现有的经营范围表述需同步变更为《经营范围规范表述目录（试行）》中对应的规范表 述，为适应工商登记分类变化，公司对经营范围进行相应规范调整，由"白酒和其他酒生产"变更为"酒 制品生产"，公司经营范围不存在变更主业情况，未来公司将继续聚焦资源，做优做强白酒主业。 6月19日晚间，沪深两市 ...